Suppr超能文献

基于异常骨架的β-肾上腺素能受体配体的相似性和亚结构开发

Similarity- and Substructure-Based Development of β-Adrenergic Receptor Ligands Based on Unusual Scaffolds.

作者信息

Schmidt Denis, Gunera Jakub, Baker Jillian G, Kolb Peter

机构信息

Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany.

Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

出版信息

ACS Med Chem Lett. 2017 Mar 27;8(5):481-485. doi: 10.1021/acsmedchemlett.6b00363. eCollection 2017 May 11.

Abstract

The β-adrenergic receptor (βAR) is a G protein-coupled receptor (GPCR) and a well-explored target. Here, we report the discovery of 13 ligands, ten of which are novel, of this particular GPCR. They have been identified by similarity- and substructure-based searches using multiple ligands, which were described in an earlier study, as starting points. Of note, two of the molecules used as queries here distinguish themselves from other βAR antagonists by their unique scaffold. The molecules described in this work allow us to explore the ligand space around the previously reported molecules in greater detail, leading to insights into their structure-activity relationship. We also report experimental binding and selectivity data and putative binding modes for the novel molecules.

摘要

β-肾上腺素能受体(βAR)是一种G蛋白偶联受体(GPCR),也是一个经过充分研究的靶点。在此,我们报告了针对这一特定GPCR发现的13种配体,其中10种是新发现的。它们是通过以先前一项研究中描述的多种配体为起点,基于相似性和亚结构的搜索鉴定出来的。值得注意的是,这里用作查询的两个分子因其独特的骨架结构而有别于其他βAR拮抗剂。这项工作中描述的分子使我们能够更详细地探索先前报道分子周围的配体空间,从而深入了解它们的构效关系。我们还报告了新分子的实验结合和选择性数据以及推定的结合模式。

相似文献

4
Development of covalent antagonists for β1- and β2-adrenergic receptors.β1-和β2-肾上腺素能受体共价拮抗剂的研制。
Bioorg Med Chem. 2019 Jul 1;27(13):2959-2971. doi: 10.1016/j.bmc.2019.05.034. Epub 2019 May 24.
5
Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.从 DNA 编码的小分子文库中分离出的变构“β阻断剂”。
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1708-1713. doi: 10.1073/pnas.1620645114. Epub 2017 Jan 27.

本文引用的文献

2
The ChEMBL bioactivity database: an update.《ChEMBL 生物活性数据库更新》
Nucleic Acids Res. 2014 Jan;42(Database issue):D1083-90. doi: 10.1093/nar/gkt1031. Epub 2013 Nov 7.
4
Structure-based discovery of beta2-adrenergic receptor ligands.基于结构的β2-肾上腺素能受体配体的发现
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6843-8. doi: 10.1073/pnas.0812657106. Epub 2009 Apr 2.
8
How many drug targets are there?有多少种药物靶点?
Nat Rev Drug Discov. 2006 Dec;5(12):993-6. doi: 10.1038/nrd2199.
9
Site of action of beta-ligands at the human beta1-adrenoceptor.β配体在人β1肾上腺素能受体上的作用位点。
J Pharmacol Exp Ther. 2005 Jun;313(3):1163-71. doi: 10.1124/jpet.104.082875. Epub 2005 Feb 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验